Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Olatec Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Olatec Therapeutics

Olatec Therapeutics

Olatec: A NY-based biopharmaceutical firm developing oral therapeutics for a range of inflammatory diseases.

HQ
New York City, NY, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Founded in New York, Olatec Therapeutics is a privately held biopharmaceutical company committed to developing safe, oral NLRP3 antagonist therapeutics. Their core mission is to treat and prevent a wide array of acute and chronic inflammatory diseases mediated by Interleukin-1 (IL-1), such as arthritis, heart failure, and asthma. Olatec's vision is to revolutionize the treatment landscape for these conditions through innovative, patient-centric solutions.

Olatec has garnered attention from notable investors and has assembled a distinguished team of experts in biopharmaceuticals. The company's key achievements include advancing their lead compound through various stages of clinical trials, demonstrating significant potential in addressing unmet medical needs. Olatec's impact lies in its pioneering approach to inflammation management, promising improved quality of life for patients worldwide.

Olatec Therapeutics - Similar Companies

Ocelot Bio logo

Ocelot Bio

ocelotbio.com

Logical Therapeutics logo

Logical Therapeutics

Halia Therapeutics logo

Halia Therapeutics

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

13 Therapeutics logo

13 Therapeutics

InflammX Therapeutics logo

InflammX Therapeutics

inflammx.com

Siolta Therapeutics logo

Siolta Therapeutics

Arete Therapeutics logo

Arete Therapeutics

Landos Biopharma logo

Landos Biopharma

Oligomerix logo

Oligomerix

oligomerix.com

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Thelium Therapeutics logo

Thelium Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

Olatec Therapeutics - Quick Facts

Who are Olatec Therapeutics' competitors?

Companies similar to Olatec Therapeutics include Ocelot Bio, Logical Therapeutics, Halia Therapeutics and Osprey Pharmaceuticals USA.

When was Olatec Therapeutics founded?

Olatec Therapeutics was founded in 2003.

Where is Olatec Therapeutics' headquarters located?

Olatec Therapeutics' headquarters is located in New York City, NY, US.

How much has Olatec Therapeutics raised to-date?

As of Mar 10, 2023, Olatec Therapeutics has raised a total of $102.3M (USD).

How many employees does Olatec Therapeutics have?

Olatec Therapeutics has 14 employees as of Feb 4, 2024.

Olatec Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified